Hebei Hejia Pharmaceutical Technology Group Co., Ltd ( abbreviated as “Hejia Pharmaceutical”, stock ticker: 838641), was established in 1999, an innovative market maker and high-tech enterprise on the NEEQ (National Equities Exchange and Quotations). Hejia Pharmaceutical has three wholly owned subsidiaries, Harbin Hejia Pharmaceutical Co., Ltd., Shijiazhuang Hejia Chemical Co., Ltd., Shijiazhuang Zhongdan Chemical Co., Ltd., and one holding subsidiary -Heilongjiang Jiahao Pharmaceutical Technology Co., Ltd., and one independent professional R&D institution - Hejia Research Institute.
Hejia Pharmaceutical is located at No. 80 Hainan Road, Economic and Technological Development Zone, Shijiazhuang. By virtue of cephalosporins has developed into a major domestic pharmaceutical intermediates of cephalosporin antibiotics side chain intermediates manufacturer, and formed a relatively complete industrial chain cephalosporins intermediates. The company's main products are AE active esters, triazine rings and other fine chemical products. Development and production of a new type of biodegradable surfactants APG, expanding the company's direction. The company has strong technical force, complete testing methods, and its excellent product quality is widely praised by customers at home and abroad. It has the qualification of city-level enterprise technology center, and has passed ISO9001 certification, ISO14001 certification, and OHSAS18001 certification.>
The company has a new version of GMP certificate, capable of producing multiple cephalosporin antibiotic raw materials and preparations, and has a complete process and equipment for Chinese medicine extraction and production of Chinese medicine preparations. The company's main products sell well in domestic and foreign markets, and are committed to becoming an international brand of cephalosporin antibiotics. At the same time, the company vigorously expands the field of Chinese medicine and provides customers with high-quality Chinese medicine products.